Gautam S. Ghatnekar

Connexin43 Carboxyl-Terminal Peptides Reduce Scar Progenitor and Promote Regenerative Healing Following Skin Wounding

Gautam S. Ghatnekar, Michael P. O’Quinn, L. Jane Jourdan et al. · Regenerative Medicine · 2009 · 134 citations · Full text

The Effect of a Connexin43-Based Peptide on the Healing of Chronic Venous Leg Ulcers: A Multicenter, Randomized Trial

Gautam S. Ghatnekar, Christina L. Grek, David G. Armstrong et al. · Journal of Investigative Dermatology · 2014 · 109 citations · Full text

Topical administration of a connexin43‐based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial

Christina L. Grek, Guru Prasad, Vijay Viswanathan et al. · Wound Repair and Regeneration · 2015 · 94 citations · Full text

Inflammation, Diabetes, Pharmacology +14

Diazoxide Prevents Diabetes through Inhibiting Pancreatic β-Cells from Apoptosis via Bcl-2/Bax Rate and p38-β Mitogen-Activated Protein Kinase

Qin Huang, Shizhong Bu, Yongwei Yu et al. · Endocrinology · 2006 · 65 citations

Targeting connexin 43 with α–connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1

Christina L. Grek, J. Matthew Rhett, Jaclynn S. Bruce et al. · BMC Cancer · 2015 · 62 citations · Full text